Golden rules for registrars
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Particular attention should be paid to men and patients who are over the age of 65 in the year after the first presentation of an alarm symptom.
The evidence base for using alarm symptoms to identify cancer has been weak, and GPs often use individual approaches to the collection and analysis of data in the course of consultations.
But researchers from Kings College London have identified the likelihood of being diagnosed with a related cancer after the first episode of four common alarm symptoms - haematuria, haemoptysis, dysphagia and rectal bleeding - often encountered in primary care.
For the study, first occurrences of the alarm symptoms were identified in 762,325 patients aged 15 and older.
They found that 59 per cent of men and 51 per cent of women developed urinary tract cancer within three years of being found to have haematuria.
Fifty eight per cent of men and 54 per cent of women developed oesophageal cancer after a diagnosis of dysphagia.
However, alarm symptoms for haemoptysis had a lower sensitivity for a diagnosis of respiratory tract cancer, with only 22 per cent of men and 13 per cent of women developing the cancer.
Rectal bleeding led to a diagnosis of rectal cancer in 33 per cent in men and 25 per cent in women.
The researchers found that the increased likelihood of a diagnosis of cancer remained high during the first year after an alarm symptom but gradually declined over time and was not significantly high after five years.
What do you think? Comment below or email healthcare.republic@haymarket.com
Quick search - use * for an abbreviated search, eg nico*
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more
Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more
Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more
Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more
Comments
Only registered users may comment. Log in now or register for a free account.